The notices it replaced
- Reissues: PAR-21-134 Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
- 2 steps back: RFA-MH-18-705 Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33- Clinical Trial Required)
- 3 steps back: RFA-MH-17-606 Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33)
- 4 steps back: RFA-MH-16-400 Exploratory Clinical Trials of Novel Interventions for Mental Disorders (R33)
- 5 steps back: RFA-MH-15-310 Exploratory Clinical Trials of Novel Interventions for Mental Disorders (R33)
Who won it before
9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,835,838 in first-year total cost, median $728,237.
Most frequent study sections
- Special Emphasis Panel[ZMH1 ERB-G (08)]2
- Special Emphasis Panel[ZMH1 ERB-B (02)]1
- Special Emphasis Panel[ZMH1 ERB-D (01)]1
- Special Emphasis Panel[ZMH1 ERB-D (03)]1
- Special Emphasis Panel[ZMH1 ERB-D (07)]1
Most frequent institutions
- UNIVERSITY OF CALIFORNIA, SAN DIEGO2
- DUKE UNIVERSITY1
- HARTFORD HOSPITAL1
- QUEENS COLLEGE1
- UNIVERSITY OF CALIFORNIA LOS ANGELES1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Unconscious reduction of fear through decoded neuro-reinforcement1R33MH135002-01 · under PAR-21-134 | CRASKE, MICHELLE GMOBBS, DEAN | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $728,237 | ZMH1 |
| 2021 | Neurally targeted group intervention to reduce early childhood anxiety1R33MH121641-01A1 · under RFA-MH-18-705 | FITZGERALD, KATE DIMONDMOSER, JASON SCOTROSENBLUM, KATHERINE | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $968,223 | ZMH1 |
| 2021 | Feeling and Body Investigators (FBI)-ARFID Division: Sensory and Somatic Exposure for Children with Avoidant Restrictive Food Intake Disorder1R33MH121549-01A1 · under RFA-MH-18-705 | SAPIRO, GUILLERMO RZUCKER, NANCY L | DUKE UNIVERSITY, NC | $753,701 | ZMH1 |
| 2021 | Memantine augmentation of cognitive training in schizophrenia1R33MH125114-01 · under RFA-MH-18-705 | LIGHT, GREGORY A | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $752,089 | ZMH1 |
| 2021 | Optimizing placebo effects in depressed older adults: Enhancing processing speed and executive functioning with computerized cognitive training1R33MH126187-01 · under RFA-MH-18-705 | SNEED, JOEL R. | QUEENS COLLEGE, NY | $406,660 | ZMH1 |
| 2020 | Pharmacologic augmentation of targeted cognitive training in schizophrenia1R33MH123603-01 · under RFA-MH-18-705 | SWERDLOW, NEAL R | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $749,328 | ZMH1 |
| 2020 | Enhancing Social Competence in Adults with Autism Spectrum Disorder: A Pilot RCT1R33MH120149-01A1 · under RFA-MH-18-705 | CORBETT, BLYTHE ANNE | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $496,224 | ZMH1 |
| 2018 | Neurofeedback Processing Speed Training to Improve Social Functioning in Teenagers and Young Adults at Clinical High Risk for Psychosis1R33MH111850-01A1 · under RFA-MH-17-606 | CHOI, JIMMY | HARTFORD HOSPITAL, CT | $320,068 | ZMH1 |
| 2017 | Development of Attention Bias Modification for Depression1R33MH109600-01A1 · under RFA-MH-16-400 | BEEVERS, CHRISTOPHER GSCHNYER, DAVID M | UNIVERSITY OF TEXAS AT AUSTIN, TX | $661,308 | ZMH1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.